C. Källander

发表

Decreased Phenotypic Susceptibility to Etravirine in Patients with Predicted Genotypic Sensitivity

R. Paredes, A. Sönnerborg, M. Noguera-Julián, 2014, PloS one.

Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testing

A. Sönnerborg, J. Lennerstrand, T. Unge, 2003, AIDS.

Application of an in vitro assay for serum thymidine kinase: Results on viral disease and malignancies in humans

U. Pettersson, H. Hagberg, J. Gronowitz, 1984, International journal of cancer.

The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.

H. Hagberg, B. Simonsson, J. Gronowitz, 1983, British Journal of Cancer.

Phylogeny-Directed Search for Murine Leukemia Virus-Like Retroviruses in Vertebrate Genomes and in Patients Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Prostate Cancer

J. Blomberg, G. Sperber, R. Pipkorn, 2011, Advances in virology.

HIV reverse transcriptase inhibiting antibodies detected by a new technique: Relation to p24 and gp41 antibodies, HIV antigenemia and clinical variables

J. Lennerstrand, A. Karlsson, R. Thorstensson, 1991, Journal of medical virology.

Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.

B. Glimelius, C. Sundström, J. Gronowitz, 1995, British Journal of Cancer.

A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity.

M. Bendinelli, D. Matteucci, J. Gronowitz, 1998, Journal of virological methods.

Colorimetric Assays for Evaluation of the Mode of Action of Human Immunodeficiency Virus Type 1 Non-Nucleoside Reverse Transcriptase Inhibitors

L. Vrang, J. Gronowitz, X. Shao, 1998, Antiviral chemistry & chemotherapy.

HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma

T. Leitner, E. Sandström, J. Gronowitz, 2003, Journal of medical virology.

Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings?

P. Ashorn, Soham Gupta, A. De Costa, 2016, BMJ Open.

Evaluation of etravirine resistance in clinical samples by a simple phenotypic Test

A. Sönnerborg, P. Nowak, Eva Agneskog, 2013, Journal of medical virology.

Reverse transcriptase viral load correlates with RNA in SIV/SHIV-infected macaques.

N. Berry, R. Thorstensson, A. Mörner, 2006, AIDS research and human retroviruses.

Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strains.

E. Fenyö, R. Thorstensson, J. Gronowitz, 1998, AIDS research and human retroviruses.

Measurement of levels of human immunodeficiency virus type 1 reverse transcriptase (RT) and RT activity-blocking antibody in human serum by a new standardized colorimetric assay

R. Thorstensson, J. Gronowitz, D. Ekstrand, 1997, Journal of clinical microbiology.

A sensitive assay for the quantification of reverse transcriptase activity based on the use of carrier‐bound template and non‐radioactive‐product detection, with special reference to human‐immunodeficiency‐virus isolation

J. Gronowitz, D. Ekstrand, C. Källander, 1996, Biotechnology and applied biochemistry.

Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA

J. Gronowitz, M. Neumüller, C. Källander, 1990, Molecular and Cellular Biochemistry.

Improved HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma

T. Leitner, E. Sandström, X. Shao, 2005, Journal of medical virology.

Human serum antibodies to varicella-zoster virus thymidine kinase

J. Gronowitz, C. Källander, E. Torfason, 1982, Infection and immunity.

Deoxythymidine-kinase in cerebrospinal fluid: A new potential “marker” for brain tumours

H. Hagberg, J. Gronowitz, L. Persson, 2005, Acta Neurochirurgica.

Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis

O. Brodin, S. Nilsson, J. Gronowitz, 1990, Cancer.

Optimized assay for thymidine kinase and its application to the detection of antibodies against herpes simplex virus type 1- and 2-induced thymidine kinase

J. Gronowitz, C. Källander, 1980, Infection and immunity.

Effect of acyclovir and presence of cellular and viral thymidine kinase activity in herpes simplex virus infected cells

J. Harmenberg, J. Gronowitz, C. Källander, 2005, Archives of Virology.

Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase

A. Larsson, C. Källander, G. Abele, 1986, Antimicrobial Agents and Chemotherapy.

Thymidine kinase in brain-tumor cysts.

J. Gronowitz, L. Persson, C. Källander, 1985, Journal of neurosurgery.

Rapid typing of herpes simplex virus based on immunological specificity of viral thymidine kinase and typing according to sensitivity to iododeoxyuridine

S. Jeansson, J. Gronowitz, C. Källander, 1982, Journal of clinical microbiology.

Antibodies against varicella‐zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections

E. Olding-Stenkvist, J. Gronowitz, C. Källander, 1989, Journal of medical virology.

Relevance of Viral Thymidine Kinase for Clinical Resistance to Antiviral Drugs When Treating Herpes Simplex Eye Infections

J. Gronowitz, P. Wistrand, C. Källander, 1985 .

Rapid diagnosis of varicella-zoster virus infection by detection of viral deoxythymidine kinase in serum and vesicle fluid

E. Olding-Stenkvist, J. Gronowitz, C. Källander, 1983, Journal of clinical microbiology.

A sensitive assay for detection of deoxythymidine kinase and its application to herpesvirus diagnosis.

J. Gronowitz, C. Källander, 1983, Current topics in microbiology and immunology.

Mothers of children with Down syndrome have higher herpes simplex virus type 2 (HSV-2) antibody levels

G. Annéren, J. Gronowitz, C. Källander, 2004, Human Genetics.

Occurrence of antibodies against herpes simplex virus thymidine kinase in human sera

J. Gronowitz, C. Källander, 1981, Journal of medical virology.

Thymidine kinase in extracts of human brain tumours

L. Persson, C. Källander, S. Gronowitz, 2005, Acta Neurochirurgica.

Mutations conferring drug resistance affect eukaryotic expression of HIV type 1 reverse transcriptase.

B. Zuber, B. Wahrén, S. Kochetkov, 2004, AIDS research and human retroviruses.

Reverse transcriptase-based DNA vaccines against drug-resistant HIV-1 tested in a mouse model.

B. Zuber, B. Wahrén, S. Kochetkov, 2004, Vaccine.

Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypes.

J. Albert, T. Unge, J. Gronowitz, 2000, AIDS research and human retroviruses.

Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia

B Simonsson, H. Hagberg, B. Simonsson, 1984, Cancer.

Serum deoxythymidine kinase in small cell carcinoma of the lung: Relation to clinical features, prognosis, and other biochemical markers

J. Bergh, H. Hagberg, J. Gronowitz, 1986, Cancer.

Varicella zoster virus deoxythymidine kinase is present in serum before the onset of varicella.

E. Olding-Stenkvist, J. Gronowitz, C. Källander, 1989, Scandinavian journal of infectious diseases.

Serum thymidine kinase in transplant patients: its relation to cytomegalovirus activity, renal transplant rejection and its use for monitoring of antiviral therapy.

G. Tufveson, J. Gronowitz, O. Sjöberg, 1986, Annals of clinical research.

Deoxythymidine kinase, a possible marker for monitoring activity of cytomegalovirus infection after renal transplantation.

G. Tufveson, J. Gronowitz, E. Larsson, 1986, Scandinavian journal of urology and nephrology.

Solid‐Phase Radioimmunoassay of Serum IgG, IgM, and IgA Antibodies to Cytomegalovirus

C. Källander, E. Torfason, P. Halonen, 1981, Journal of medical virology.

Clinical and Serologic Markers of Stage and Prognosis in Small Cell Lung Cancer

R. Bergström, S. Påhlman, J. Gronowitz, 1990 .

Application of a Chain Termination Assay for Characterization of Reverse Transcriptase from AZT-Resistant HIV Isolates

L. Vrang, J. Lennerstrand, C. Källander, 1996 .

HIV‐1 reverse transcriptase inhibiting antibody titer in serum: Relation to disease progression and to core‐antibody levels

J. Lennerstrand, A. Karlsson, M. Neumüller, 1992, Journal of medical virology.